Viewing Study NCT06654700


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2025-12-26 @ 12:18 PM
Study NCT ID: NCT06654700
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-20
First Post: 2024-10-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
Sponsor: MAXVAX Biotechnology Limited Liability Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module